Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Expanded Access IND to Evaluate the Safety and Efficacy of Autologous HB-adMSCs for the Treatment of a Single Patient With Polyneuropathy

NCT04064983 is registered in ClinicalTrials.gov with Hope Biosciences Research Foundation as lead sponsor.

NCT NCT04064983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04064983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Expanded Access IND to Evaluate the Safety and Efficacy of Autologous HB-adMSCs for the Treatment of a Single Patient With Polyneuropathy
Lead sponsor
Hope Biosciences Research Foundation
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polyneuropathies